Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

Clinical trial NCT00450086 · COMPLETED

Trial details

NCT number: NCT00450086
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Collagenous Colitis

Start date: 2007-03-01
Primary completion: 2011-06-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.